Reuters logo
2 个月前
BRIEF-HTG Molecular amends, restates IVD test development, component supply agreement with Illumina
2017年6月5日 / 中午12点17分 / 2 个月前

BRIEF-HTG Molecular amends, restates IVD test development, component supply agreement with Illumina

June 5 (Reuters) - HTG Molecular Diagnostics Inc:

* Amended and restated its IVD test development and component supply agreement with Illumina

* HTG Molecular Diagnostics - agreement extends term, increases number of in-vitro diagnostic test kits that may be developed with Illumina sequencing technology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below